# Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

> **NCT00708175** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 156 (actual)

## Conditions studied

- Bone Metabolism

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00708175
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708175, "Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00708175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*